Loading
Total declarations
Company
▲ Purchases (23 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Dec 2016 for REPROS THERAPEUTICS INC., €30k.
Filing timeline
BuySaleJoseph Podolski
Insider track record
Disclosed buys
23
Disclosed sells
0
Signal history
Closed purchases
Market purchases
23
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joseph Podolski: trading record in brief
Joseph Podolski discloses dealings in Repros Therapeutics Inc. to SEC (Form 4). The record holds 23 filings, for trades running from 3 January 2006 to 9 December 2016.
Purchases make up the whole of the open-market record (23 purchases, €298k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2016 to date brings 4 purchases and no sales.
A typical purchase (the median) is worth €8,796. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 9 December 2016, the filings show an open-market purchase worth €30k in Repros Therapeutics Inc. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joseph Podolski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
20,000 shares@ US$1.6058.7% of flowCommon StockSEC:0001144204-16-138799:0
Canonical exit: 9 Mar 2017 (T+90)
10,000 shares@ US$0.9316.3% of flowCommon StockSEC:0001144204-16-083401:0
Canonical exit: 18 May 2016 (T+90)
3,500 shares@ US$1.1428.9% of flowCommon StockSEC:0001144204-16-074666:1
Canonical exit: 6 Apr 2016 (T+90)
8,177 shares@ US$1.19971.1% of flowCommon StockSEC:0001144204-16-074666:0
Canonical exit: 5 Apr 2016 (T+90)
4,700 shares@ US$9.42Common StockSEC:0001144204-14-067291:0
Canonical exit: 10 Feb 2015 (T+90)
2,100 shares@ US$13.91Common StockSEC:0001144204-14-050112:0
Canonical exit: 12 Nov 2014 (T+90)
3,000 shares@ US$18.03Common StockSEC:0001208491-13-000001:0
Canonical exit: 23 Jan 2014 (T+90)
5,000 shares@ US$3.99Common StockSEC:0001181431-12-014722:0
Canonical exit: 3 Jun 2012 (T+90)
13,000 shares@ US$1.37Common StockSEC:0001181431-10-051078:0
Canonical exit: 13 Jan 2011 (T+90)
12,500 shares@ US$0.4296Common StockSEC:0001181431-10-034469:0
Canonical exit: 20 Sept 2010 (T+90)
20,000 shares@ US$0.4505Common StockSEC:0001181431-10-034469:1
Canonical exit: 20 Sept 2010 (T+90)
4,000 shares@ US$6.41Common StockSEC:0001181431-09-014012:0
Canonical exit: 3 Jun 2009 (T+90)
4,000 shares@ US$7.14Common StockSEC:0001209191-08-055663:0
Canonical exit: 5 Jan 2009 (T+90)
400 shares@ US$7.18Common StockSEC:0001209191-08-055663:1
Canonical exit: 5 Jan 2009 (T+90)
1,500 shares@ US$8.86Common StockSEC:0001181431-08-025342:0
Canonical exit: 15 Jul 2008 (T+90)
1,000 shares@ US$9.00Common StockSEC:0001181431-08-024528:0
Canonical exit: 8 Jul 2008 (T+90)
1,000 shares@ US$9.36Common StockSEC:0001181431-08-000063:0
Canonical exit: 30 Mar 2008 (T+90)
1,000 shares@ US$12.66Common StockSEC:0001181431-07-063884:0
Canonical exit: 23 Jan 2008 (T+90)
1,500 shares@ US$5.90Common StockSEC:0001181431-06-066956:0
Canonical exit: 1 Mar 2007 (T+90)
2,000 shares@ US$5.71Common StockSEC:0001181431-06-063479:0
Canonical exit: 12 Feb 2007 (T+90)
2,000 shares@ US$8.18Common StockSEC:0001181431-06-060454:0
Canonical exit: 25 Jan 2007 (T+90)
1,000 shares@ US$10.99Common StockSEC:0001181431-06-028284:0
Canonical exit: 3 Aug 2006 (T+90)
700 shares@ US$4.98Common StockSEC:0001181431-06-000282:0
Canonical exit: 3 Apr 2006 (T+90)
23 of 23 declarations
